Nuzenio

Obinutuzumab

Obinutuzumab news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 3 latest news signals 3 publisher sources 100/100 entity strength

Latest news

Obinutuzumab for Rituximab-Intolerant Minimal Change Disease: A Case Report and Review of Recent Literature - CureusCureus · Mon, 10 Aug 2026 18:41:24 GMTFirst experience with obinutuzumab in a juvenile-onset systemic lupus erythematosus patient with rituximab-associated posterior reversible encephalopathy syndrome - springermedicine.comspringermedicine.com · Fri, 07 Aug 2026 07:00:00 GMTFrontline Zanubrutinib Plus Obinutuzumab Elicits Complete Responses in Older Patients With MCL - OncLiveOncLive · Mon, 03 Aug 2026 13:08:13 GMT

Timeline

Mon, 10 Aug 2026 18:41:24 GMTObinutuzumab for Rituximab-Intolerant Minimal Change Disease: A Case Report and Review of Recent Literature - Cureus
Fri, 07 Aug 2026 07:00:00 GMTFirst experience with obinutuzumab in a juvenile-onset systemic lupus erythematosus patient with rituximab-associated posterior reversible encephalopathy syndrome - springermedicine.com
Mon, 03 Aug 2026 13:08:13 GMTFrontline Zanubrutinib Plus Obinutuzumab Elicits Complete Responses in Older Patients With MCL - OncLive

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Obinutuzumab.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

3 distinct publisher/source names are currently connected to this entity page.